We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Hoping Clearer Definition of Co-Crystals Stimulates Production
FDA Hoping Clearer Definition of Co-Crystals Stimulates Production
To shed light on the regulatory requirements for production of co-crystals, the FDA is offering drugmakers submitting ANDAs and NDAs a clearer definition of co-crystals that no longer denotes them as an in-process material.